Status:
COMPLETED
Effect of Moringa Oleifera Dehydrated Leaf Powder on the Components of Metabolic Syndrome in Mexican Adults.
Lead Sponsor:
Universidad de Colima
Collaborating Sponsors:
Instituto Mexicano del Seguro Social
Conditions:
Nutritional and Metabolic Diseases
Metabolic Syndrome
Eligibility:
All Genders
25-59 years
Phase:
NA
Brief Summary
Background: The increase in chronic degenerative diseases caused by Metabolic Syndrome (MS) has prompted the search for natural alternatives to develop new medications and to know the mechanism and do...
Detailed Description
1. . Data collection. The patients are being recruited from the medical consultation of the UMF 19 of the IMSS Colima. Participants must have a previous Metabolic Syndrome diagnosis in their medical r...
Eligibility Criteria
Inclusion
- Beneficiaries of the medical consultation of the Instituto Mexicano del Seguro Social (IMSS), Colima
- \- Female and male gender
- People with 3 diagnostic variables of metabolic syndrome according to the standardization of criteria established for the diagnosis of Metabolic Syndrome (2009).
- Patients under treatment for components of metabolic syndrome (dyslipidemia, diabetes, arterial hypertension)
- Signed informed consent
Exclusion
- Conditions that do not allow blood collection
- Patients with metabolic syndrome who currently follow a nutritional plan and/or do exercise
- Pregnant women
- Smokers
- Patients with hypothyroidism and hyperthyroidism, cancer, renal failure and/or liver cirrhosis
- Patients with any complication of diabetes mellitus
- Patients on insulin therapy
- People who take botanical extracts or a multivitamin
- People with food allergies
- Acute infection in progress at the time of blood sample collection
- Patients must not be participating in another study alternately
- Elimination Criteria
- Insufficient, coagulated or hemolyzed serum sample.
- Patients who interrupt treatment or who do not wish to continue.
- Patients who present side effects (nausea, vomiting, diarrhea, stomach pain) or any symptom related to discomfort, allergy or intolerance with the consumption of Moringa oleifera leaf powder that does not disappear in a period of 3 days.
Key Trial Info
Start Date :
January 5 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 30 2024
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT07194577
Start Date
January 5 2023
End Date
October 30 2024
Last Update
September 26 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Unidad de Medicina Familiar No.19, Instituto Mexicano del Seguro Social
Colima, Centro, Mexico, 28000